Quick Answer
Encompass Health Corp reported Net Income Loss of $566.20 million for the year ending 2025.
- Encompass Health Corp showed an increase of +24.2% in Net Income Loss from 2024 to 2025.
- This data is from Encompass Health Corp's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2014: $42.10 million | Q1 2015: $42.50 million | Q2 2015: $42.90 million | Q3 2015: $50.70 million | Q4 2015: $47.00 million | Q1 2016: $58.00 million | Q2 2016: $62.60 million | Q3 2016: $61.70 million | Q4 2016: $65.30 million | Q1 2017: $66.80 million | Q2 2017: $63.00 million | Q3 2017: $65.90 million | Q4 2017: $75.40 million | Q1 2018: $83.80 million | Q2 2018: $91.80 million | Q3 2018: $88.60 million | Q4 2018: $28.10 million | Q1 2019: $102.30 million | Q2 2019: $91.20 million | Q3 2019: $97.60 million | Q4 2019: $67.60 million | Q1 2020: $87.00 million | Q2 2020: $33.50 million | Q3 2020: $77.70 million | Q4 2020: $86.00 million | Q1 2021: $107.30 million | Q2 2021: $113.30 million | Q3 2021: $100.00 million | Q4 2021: $91.60 million | Q1 2022: $87.50 million | Q2 2022: $48.70 million | Q3 2022: $45.40 million | Q4 2022: $89.40 million | Q1 2023: $87.70 million | Q2 2023: $91.40 million | Q3 2023: $85.30 million | Q1 2024: $112.50 million | Q2 2024: $114.10 million | Q3 2024: $108.20 million | Q1 2025: $151.50 million | Q2 2025: $142.10 million | Q3 2025: $126.50 million.
- Over the full 18 years of available data (2008 to 2025), Encompass Health Corp's Net Income Loss has grown by 124.3%.
- Historical annual values: Fiscal year 2025: $566.20 million | Fiscal year 2024: $455.70 million | Fiscal year 2023: $352.00 million | Fiscal year 2022: $271.00 million | Fiscal year 2021: $412.20 million | Fiscal year 2020: $284.20 million | Fiscal year 2019: $358.70 million | Fiscal year 2018: $292.30 million | Fiscal year 2017: $271.10 million | Fiscal year 2016: $247.60 million | Fiscal year 2015: $183.10 million | Fiscal year 2014: $222.00 million | Fiscal year 2013: $323.60 million | Fiscal year 2012: $185.00 million | Fiscal year 2011: $208.70 million | Fiscal year 2010: $899.00 million | Fiscal year 2009: $94.80 million | Fiscal year 2008: $252.40 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: